InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2023-07-05 00:00:00 ET · period of report 2023-07-01 · accession 0001209191-23-041212 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-07-05 2023-07-01 WGS White Karen Ann CHRO M - OptEx — +99 4,730 +2% —
D 2023-07-05 2023-07-03 WGS White Karen Ann CHRO S - Sale+OE $5.99 -45 4,685 -1.0% -$269.55
D 2023-07-05 2023-07-01 WGS White Karen Ann CHRO M - OptEx $0.00 -99 1,092 -8% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2023-07-01 M A 99 — 4,730 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
2 Common Class A Common Stock 2023-07-03 S D 45 $5.99 4,685 D — —
3 Derivative Restricted Stock Unit 2023-07-01 M D 99 $0.00 1,092 D — · — to — 99 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) 6.25% vest in quarterly installments over the 4-year period commencing on April 4, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date